Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.350
+0.090 (3.99%)
Nov 21, 2024, 1:43 PM EST - Market open

Oramed Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Aug '21 Dec '20 2019 - 2015
Revenue
-1.342.72.712.72.71
Upgrade
Revenue Growth (YoY)
--50.43%-0.33%0.33%-0.33%0.07%
Upgrade
Gross Profit
-1.342.72.712.72.71
Upgrade
Selling, General & Admin
6.438.1415.6612.585.944.73
Upgrade
Research & Development
6.638.9727.6427.1120.9920.67
Upgrade
Operating Expenses
13.0617.1143.339.6926.9325.4
Upgrade
Operating Income
-13.06-15.77-40.6-36.98-24.22-22.68
Upgrade
Interest Expense
-2.06-2.04----0.07
Upgrade
Interest & Investment Income
7.428.033.570.470.350.78
Upgrade
Currency Exchange Gain (Loss)
-0.12-0.120.18-0.03-0-
Upgrade
Other Non Operating Income (Expenses)
-1.4-1.4-0.01-0.01-0.01-
Upgrade
EBT Excluding Unusual Items
-9.23-11.3-36.86-36.55-23.88-21.97
Upgrade
Gain (Loss) on Sale of Investments
16.3916.39-0.81-0.220.9-
Upgrade
Pretax Income
7.165.09-37.66-36.77-22.99-21.97
Upgrade
Income Tax Expense
2.77-0.1---
Upgrade
Earnings From Continuing Operations
4.395.09-37.76-36.77-22.99-21.97
Upgrade
Minority Interest in Earnings
0.070.441.21.760.75-
Upgrade
Net Income
4.475.53-36.56-35-22.24-21.97
Upgrade
Net Income to Common
4.475.53-36.56-35-22.24-21.97
Upgrade
Shares Outstanding (Basic)
414039372824
Upgrade
Shares Outstanding (Diluted)
414139372824
Upgrade
Shares Change (YoY)
2.51%4.02%5.08%30.36%16.71%18.81%
Upgrade
EPS (Basic)
0.110.14-0.94-0.94-0.78-0.90
Upgrade
EPS (Diluted)
0.110.14-0.94-0.94-0.78-0.90
Upgrade
Free Cash Flow
-7.93-10.55-28.41-33.39-21.56-25.75
Upgrade
Free Cash Flow Per Share
-0.19-0.26-0.73-0.90-0.76-1.06
Upgrade
Gross Margin
-100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
--1176.79%-1501.96%-1363.50%-896.15%-836.39%
Upgrade
Profit Margin
-412.31%-1352.61%-1290.71%-822.72%-810.18%
Upgrade
Free Cash Flow Margin
--787.24%-1051.20%-1231.31%-797.48%-949.45%
Upgrade
EBITDA
-12.85-15.57-40.54-36.92-24.15-22.66
Upgrade
D&A For EBITDA
0.220.20.060.050.080.02
Upgrade
EBIT
-13.06-15.77-40.6-36.98-24.22-22.68
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.